摘要

Medical thromboprophylaxis reduces venous thromboembolism (VTE), while causing bleeding. Routine application of pharmacological VTE prophylaxis to low risk medical patients is likely to cause net harm; as a result only moderate or high risk patients should be exposed to VTE prophylaxis. To avoid unneeded exposure to VTE prophylaxis health care providers should use an %26quot;opt-in%26quot; policy which does not default to the use of VTE prophylaxis in inappropriate patients.

  • 出版日期2013-4

全文